Delivery Order SPE2DB20D1004-SPE2DB22FF2E4

Award Date 2/8/22
Potential Completion Date 2/9/22
Potential Value $4.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.40 firm fixed-price delivery order is for the supply of Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles. The contract has an ultimate completion date of May 7, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,178.99 firm fixed-price delivery order contract covers the supply of 4566832016 - Potassium Phosphate 45 mmol/15 ml, a pharmaceutical product, with a period of performance through January 6, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds an Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of potassium chloride extended-release tablets in 500-count packages, with a total ceiling value of $4,468.05 and a period of performance through June 30, 2025. The contract is a firm-fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $10,015.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D3301|SPE2DB25FY4GX) for the supply of 4568142788 - POTASSIUM CL 10% (40 MEQ/30 ML) CUP UD 30 ML. The award has a firm fixed price pricing type and an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,294.26 Firm Fixed Price Delivery Order contract is for the supply of 4563216276 Potassium Cl ER 20 MEQ Tablets in 500-count packages. The contract has an ultimate completion date of January 3, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $2,058.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4557842594 POTASSIUM CL ER 10 MEQ TABLET 1000S, with a completion date of July 20, 2022. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,458.46, is for the delivery of Potassium Chloride Extended-Release 20 MEQ Tablets in 1,000-count bottles. The contract is for a period ending on June 18, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award, valued at $1,247.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Potassium Phosphate 45 MMOL/15 ML, a medication, with a completion date of June 27, 2025. The contract is designated as a Firm Fixed Price Delivery Order and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a $1,668.94 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of potassium chloride, a medical product, with a period of performance ending on May 22, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,667.92, is for the delivery of Potassium Chloride 10% (20 MEQ/15ML) UD 15ML, a medical product. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at $999,999,999 and runs through...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FF2E4
    Delivery Order

This federal contract award is for the delivery of Potassium Chloride Extended-Release Tablets (500 count) to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $4,170.31, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order contract, with no set-aside designation.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 10:37 AM